|
|
|
|
LEADER |
03100nam a22005535i 4500 |
001 |
978-88-470-0391-0 |
003 |
DE-He213 |
005 |
20151204173521.0 |
007 |
cr nn 008mamaa |
008 |
100301s2007 it | s |||| 0|eng d |
020 |
|
|
|a 9788847003910
|9 978-88-470-0391-0
|
024 |
7 |
|
|a 10.1007/978-88-470-0391-0
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC346-429.2
|
072 |
|
7 |
|a MJN
|2 bicssc
|
072 |
|
7 |
|a MED056000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8
|2 23
|
245 |
1 |
0 |
|a Neurodegeneration in Multiple Sclerosis
|h [electronic resource] /
|c edited by Massimo Filippi, Marco Rovaris, Giancarlo Comi.
|
264 |
|
1 |
|a Milano :
|b Springer Milan,
|c 2007.
|
300 |
|
|
|a XI, 236 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Topics in Neuroscience
|
505 |
0 |
|
|a Background -- Neuropathological Advances in Multiple Sclerosis -- Neurophysiology -- MRI Techniques to Assess Neurodegeneration -- Atrophy -- T1 Black Holes and Gray Matter Damage -- Magnetization Transfer Imaging -- Perfusion MR I -- Diffusion-Weighted Imaging -- Proton MR Spectroscopy -- Functional MRI -- Evaluation of MRI Outcomes -- Validation of MRI Surrogates -- Defining Responders and Non-responders -- Predictive Models in Multimodal Imaging -- Lessons from Other Neurodegenerative Diseases -- Alzheimer’s Disease -- Other Neurodegenerative Conditions -- Incorporation of Other Biomarkers -- Designing MS Trials for Neurodegeneration -- Critical Review of Existing Trials -- Design for the Next Trials of Neurodegeneration.
|
520 |
|
|
|a In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS pathology, known to occur in and outside macroscopic lesions. Modern quantitative MR techniques have the potential to overcome the limitations of cMRI, and their application is dramatically changing our understanding of how MS causes irreversible disability. Written by world-renowned scientists, the volume is indispensable for anybody working in this field.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Radiology.
|
650 |
|
0 |
|a Neuroradiology.
|
650 |
|
0 |
|a Nuclear medicine.
|
650 |
|
0 |
|a Neurology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Neurology.
|
650 |
2 |
4 |
|a Neurosciences.
|
650 |
2 |
4 |
|a Imaging / Radiology.
|
650 |
2 |
4 |
|a Neuroradiology.
|
650 |
2 |
4 |
|a Nuclear Medicine.
|
700 |
1 |
|
|a Filippi, Massimo.
|e editor.
|
700 |
1 |
|
|a Rovaris, Marco.
|e editor.
|
700 |
1 |
|
|a Comi, Giancarlo.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9788847003903
|
830 |
|
0 |
|a Topics in Neuroscience
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-88-470-0391-0
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|